Last viewed: NOVN


Prices are updated after-hours



nasdaq:NOVN Novan, Inc.

NOVN | $3.77 | twitter stocktwits trandingview |
Health Technology

(0.0% 1d) (-12.5% 1m) (177.2% 1y) (0.5% 2d) (-1.4% 3d) (0.0% 7d) (-100.0% volume)
http://www.novan.com
Sec Filling | Patents | 42 employees

Novan, Inc. is a biotechnology company, which engages in leveraging nitric oxide’s natural antiviral and immunomodulatory mechanisms of action to treat dermatological and oncovirus-mediated diseases. Its products pipeline include SB204, SB206, SB208, and SB414. The company was founded by Mark Schoenfisch and Nathan Stasko in 2006 and is headquartered in Morrisville, NC.

add to today's watch list email alert is off




dermatological   antiviral  

Press-releases


Novan Announces Presentation of Two Posters at the 2022 Winter Clinical Dermatology Conference
Published: 2022-01-14 (Crawled : 14:30) - globenewswire.com
NOVN | $3.77 | twitter stocktwits trandingview |
Health Technology
| | O: 0.53% H: 0.0% C: 0.0%

ces conference presentation
Novan to Participate in the Virtual Investor Roundtable Event
Published: 2021-11-12 (Crawled : 14:00) - globenewswire.com
NOVN | $3.77 | twitter stocktwits trandingview |
Health Technology
| | O: -0.9% H: 0.0% C: 0.0%


Novan Provides Corporate Update and Reports Third Quarter 2021 Financial Results
Published: 2021-11-10 (Crawled : 11:00) - globenewswire.com
NOVN | $3.77 | twitter stocktwits trandingview |
Health Technology
| | O: 3.9% H: 2.27% C: -6.52%
SYNH | $86.46 | twitter stocktwits trandingview |
Health Services
| | O: -1.13% H: 1.52% C: -0.05%

financial results results
Novan Announces Favorable Preclinical Safety Data and Intent to Advance SB019 for Treatment of COVID-19
Published: 2021-11-09 (Crawled : 14:00) - globenewswire.com
NOVN | $3.77 | twitter stocktwits trandingview |
Health Technology
| | O: -2.23% H: 0.0% C: 0.0%

covid treatment preclinical
Novan Announces Fireside Chat Hosted by Jonathan Aschoff, Ph.D. of ROTH Capital Partners
Published: 2021-11-04 (Crawled : 13:00) - globenewswire.com
NOVN | $3.77 | twitter stocktwits trandingview |
Health Technology
| | O: 1.44% H: 5.26% C: 2.7%


Novan to Report Third Quarter 2021 Financial Results on November 10, 2021
Published: 2021-11-03 (Crawled : 14:00) - globenewswire.com
NOVN | $3.77 | twitter stocktwits trandingview |
Health Technology
| | O: -0.86% H: 0.0% C: 0.0%

financial results results
Novan to Report Third Quarter 2021 Financial Results on November 10, 2021Company to host conference call and webcast on Wednesday, November 10, 2021, at 8:30 a.m. ET
Published: 2021-11-03 (Crawled : 20:00) - biospace.com/
NOVN | $3.77 | twitter stocktwits trandingview |
Health Technology
| | O: -0.86% H: 0.0% C: 0.0%

financial results results conference
Novan Appoints Brian M. Johnson as Chief Commercial Officer and Receives Conditional FDA Acceptance of Proposed Brand Name KINSOLUS™ for SB206 in Molluscum Contagiosum
Published: 2021-11-02 (Crawled : 13:00) - globenewswire.com
NOVN | $3.77 | twitter stocktwits trandingview |
Health Technology
| | O: 3.7% H: 1.0% C: -0.14%

molluscum fda fda acceptance
Novan Reports Safety Data from B-SIMPLE4 Pivotal Phase 3 Study of SB206
Published: 2021-09-23 (Crawled : 12:00) - globenewswire.com
NOVN | $3.77 | twitter stocktwits trandingview |
Health Technology
| | O: -0.24% H: 2.39% C: 0.95%

phase 3
Novan to Present at the Cantor Fitzgerald Virtual Global Healthcare Conference
Published: 2021-09-20 (Crawled : 13:15) - globenewswire.com
NOVN | $3.77 | twitter stocktwits trandingview |
Health Technology
| | O: -4.21% H: 1.59% C: 0.61%

conference
See all


Last 15 days Sec forms
File Id Form Date Direction Code Amount Transacted Owned Amount


Your Today's Watch List
Sign in to create a watchlist
Today's Insiders Buying

Yesterday's Insiders Buying